PSGL-1 as a novel therapeutic target

Drug News and Perspectives

Volumn 17, Issue 9, 2004, Pages 579-586

  Constantin, Gabriela ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CELL ADHESION MOLECULE; DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUORINE; GLYCOPEPTIDE; GLYCOSULFOPEPTIDE; L SELECTIN; MONOCLONAL ANTIBODY; MUCIN; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE PERACETYLATED 4 FLUORINATED DEXTRO GLUCOSAMINE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; RECOMBINANT ANTIBODY; RECOMBINANT P SELECTIN GLYCOPROTEIN LIGAND 1 IMMUNOGLOBULIN; SELECTIN; SULFUR DERIVATIVE; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL MODEL; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BINDING AFFINITY; BLEEDING; DRUG EFFECT; DRUG TARGETING; HUMAN; INFLAMMATION; INJURY; LEUKOCYTE MIGRATION; LEUKOCYTE ROLLING; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REPERFUSION INJURY; REVIEW; SKIN INFLAMMATION; VENOUS THROMBOEMBOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; HUMANS; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR;

EID: 12344275686     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2004.17.9.872571     Document Type: Review

References (76)

1. Butcher, E.C. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991, 67: 1033-6.
2. Springer, T.A. Traffic signals for lymphoid recirculalion and leukocyte emigration: The multi-step paradigm. Cell 1994, 76: 301-14.
3. Butcher, E.C., Williams, M., Youngman, K., Rott, L. and Briskin, M. Lymphocyte trafficking and regional immunity. Adv Immunol 1999, 72: 209-53.
4. Kansas, G.S. Selectins and their ligands: Current concepts and controversies. Blood 1996, 88: 3259-87.
5. Moore, K.L., Stults, N.L., Diaz, S. et al. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 1992, 118: 445-56.
6. Sako, D., Chang, X.J., Barone, K.M. et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993, 75: 1179-86.
7. McEver, R.P. and Cummings, R.D. Perspectives series: Cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997, 100: 485-91.
8. Leppanen, A., Yago, T., Otto, V.I., McEver, R.P. and Cummings, R.D. Model glycosulfopeptides from P-selectin glycoprotein ligand-1 require tyrosine sulfation and a core 2-branched O-glycan to bind to L-selectin. J Biol Chem 2003, 278: 26391-400.
9. Kanamori, A., Kojima, N., Ukimura, K. et al. Distinct sulfation requirements of selectins disclosed using cells that support rolling mediated by all three selectins under shear flow. L-selectin prefers carbohydrate 6-sulfation to tyrosine sulfation, whereas P-selectin does not. J Biol Chem 2002, 277: 32578-86.
10. Moore, K.L., Patel, K.D., Bruehl, R.E. et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995, 128: 661-71.
11. Norman, K.E., Katopodis, A.G., Thoma, G. et al. P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo. Blood 2000, 96: 3585-91.
12. Yang, J., Furie, B.C. and Furie, B. The biology of P-selectin glycoprotein ligand-1: Its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost 1999, 81: 1-7.
13. Sperandio, M., Smith, M.L., Forlow, S.B. et al. P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med 2003, 197: 1355-63.
14. Falati, S., Liu, Q., Gross, P. et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003, 197: 1585-98.
15. Hrachovinova, I., Cambien, B., Hafezi-Moghadam, A. et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003, 9: 1020-5.
16. Lefer, D.J. Pharmacology of selectin inhibitors in ischemia/reperfusion states. Annu Rev Pharmacol Toxicol 2000, 40: 283-94.
17. Takada, M., Nadeau, K.C., Shaw, G.D. and Tilney, N.L. Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. Transplantation 1997, 64: 1520-5.
18. Takada, M., Nadeau, K.C., Shaw, G.D., Marquette, K.A. and Tilney, N.L. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997, 99: 2682-90.
19. Fuller, T.F., Sattler, B., Binder, L., Vetterlein F., Ringe, B. and Lorf, T. Reduction of severe ischemia/reperfusion injury in rat kidney grafts by a soluble P-selectin glycoprotein ligand. Transplantation 2001, 72: 216-22.
20. Gasser, M., Waaga, A.M., Kist-Van Holthe, J.E. et al. Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand. J Am Soc Nephrol 2002, 13: 1937-45.
21. Pratschke, J., Kofla, G., Wilhelm, M.J. et al. Improvements in early behavior of rat kidney allografts after treatment of the brain-dead, donor. Ann Surg 2001, 234: 732-40.
22. Cooper, D., Chitman, K.D., Williams, M.C. and Granger, D.N. Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2003, 284: 1027-33.
23. Hicks, A.E.R., Nolan, S.L., Ridger, V.C. et al. Recombinant P-selectin glycoprotein ligand-1 directly inhibits leucocyte rolling by all 3 selecting in vivo; complete inhibition of rolling is not required for anti-inflammatory effect. Blood 2003, 101: 3249-56.
24. Kyriakides, C., Favuzza, J., Wang, Y., Austen, W.G., Jr., Moore, F.D., Jr. and Hechtman, H.B. Recombinant soluble P-selectin glycoprotein ligand 1 moderates local and remote injuries following experimental lower-torso ischaemia. Br J Surg 2001, 88: 825-30.
25. Amersi, F., Dulkanchainun, T., Nelson, S.K. et al. A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model. Transplantation 2001, 71: 112-8.
26. Dulkanchainun, T.S., Goss, J.A., Imagawa, D.K. et al. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg 1998, 227: 832-40.
27. Hayward, R., Campbell, B., Shin, Y.K., Scalia, R. and Lefer, A.M. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res 1999, 41: 65-76.
28. Wang, K., Zhou, Z., Zhou, X., Tarakji, K., Topol, E.J. and Lincoff, A.M. Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model. J Am Coll Cardiol 2001, 38: 577-82.
29. Wang, K., Zhou, X., Zhou, Z. et al. Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion. Thromb Haemost 2002, 88: 149-54.
30. Kumar, A., Villani, M.P., Patel, U.K., Keith, J.C., Jr. and Schaub, R.G. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model Circulation 1999, 99: 1363-9.
31. Alper, J. Searching for medicine's sweet spot. Science (News) 2000, 291: 2338-13.
32. Wakefield, T.W., Stricter, R.M., Schaub, R. et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. J Vasc Surg 2000, 31: 309-24.
33. Myers, D., Wrobleski, S., Londy, F. et al. New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig. Thromb Haemost 2002, 87: 374-82.
34. Eppihimer, M.J. and Schaub, R.G. P-selectin-dependent inhibition of thrombosis during venous stasis. Arterioscler Thromb Vasc Biol 2000, 20: 2483-8.
35. Myers, D.D., Jr., Henke, P.K., Wrobleski, S.K. et al. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. J Vasc Surg 2002, 36: 928-38.
36. Thanaporn, P., Myers, D.D., Wrobleski, S.K. et al. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. Surgery 2003, 134: 365-71.
37. Scalia, R., Armstead, V.E., Minchenko, A.G. and Lefer, A.M. Essential role of P-selectin in the Initiation of the inflammatory response induced by hemorrhage and reinfusion. J Exp Med 1999, 189: 931-8.
38. Scalia, R., Hayward, R., Armstead, V.E., Minchenko, A.G. and Lefer, A.M. Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte-endothelium interaction in vivo. Role in rat traumatic shock. Circ Res 1999, 84: 93-102.
39. Armstead, V.E., Minchenko, A.G., Scalia, R. and Lefer, A.M. Pulmonary tissue factor mRNA expression during murine traumatic shock: Effect of P-selectin blockade. Shock 2001, 15: 323-6.
40. Furie, B. and Furie, B.C. P-selectin induction of tissue factor biosynthesis and expression. Haemostasis 1996, 26(Suppl 1): 60-5.
41. Ramos, C.L., Huo, Y., Jung, U., et al. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 1999, 84: 1237-44.
42. Phillips, J.W., Barringhaus, K.G., Sanders, J.M. et al. Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation 2003, 107: 2244-9.
43. Lehr, H.A., Olofsson, A.M., Carew, T.E. et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoproteln in vivo. Lab Invest 1994, 71: 380-6.
44. Lehr, H.A., Frei, B. and Arfors, K.E. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci USA 1994, 91: 7688-92.
45. Fahy, J.V., Corry, D.B. and Boushey, H.A. Airway inflammation and remodeling in asthma. Curr Opin Pulm Med 2000, 6: 15-20.
46. Jatakanon, A., Uasuf, C., Maziak, W., Lim, S., Chung, K.F. and Barnes, P.J. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999, 160: 1532-9.
47. Symon, F.A., Lawrence, M.B., Williamson, M.L., Walsh, G.M., Watson, S.R. and Wardlaw, A.J. Functional and structural characterization of the eosinophil P-selectin ligand. J Immunol 1996, 157: 1711-9.
48. Edwards, B.S., Curry, M.S., Tsuji, H., Brown, D., Larson, R.S. and Sklar, L.A. Expression of P-selectin at low site density promotes selective attachment of eosinophils over neutrophils. J Immunol 2000, 165: 404-10.
49. Dang, B., Wiehler, S. and Patel, K.D. Increased PSGL-1 expression on granulocytes from allergic-asthmatic subjects results in enhanced leukocyte recruitment under flow conditions. J Leukoc Biol 2002, 72: 702-10.
50. Symon, F.A., McNulty, C.A. and Wardlaw, AJ. P- and L-selectin mediate binding of T cells to chronically inflamed human airway endothelium. Eur J Immunol 1999, 29: 1324-33.
51. Borchers, M.T., Crosby, J., Farmer, S. et al. Blockade of CD49d inhibits allergic airway pathologies independent of effects on leukocyte recruitment. Am J Physiol Lung Cell Mol Physiol 2001, 280: 813-21.
52. Strauss, E.C., Larson, K.A., Brenneise, I. et al. Soluble P-selectin glycoprotein ligand 1 inhibits ocular inflammation in a murine model of allergy. Invest Ophthalmol Vis Sci 1999, 40: 1336-42.
53. Berg, E.L., Yoshino, T., Rott, L.S. et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991, 174: 1461-6.
54. Fuhlbrigge, R.C., Kieffer, D., Armerding, D. and Kupper, T.S. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T-cells. Nature 1997, 389: 978-81.
55. Borges, E., Tietz, W., Steegmaier, M. et al. P-selectin glycoprotein ligand-1 (PSGL-1) on Thelper 1 but not on Thelper 2 cells binds to P-selectin and supports migration into inflamed skin. J Exp Med 1997, 185: 573-8.
56. Hirata, T., Furie, B.C. and Furie, B. P-, E-, and L-selectin mediate migration of activated CD8+ T lymphocytes into inflamed skin. J Immunol 2002, 169: 4307-13.
57. Robert, C., Fuhlbrigge, R.C., Kieffer, J.D. et al. Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance. J Exp Med 1999, 189: 627-36.
58. Dimitroff, C.J., Bernacki, R.J. and Sackstein, R. Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: Implications in modulating lymphocyte migration to skin. Blood 27003, 101: 602-10.
59. Dimitroff, C.J., Kupper, T.S. and Sackstein, R. Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. J Clin Invest 2003, 112: 1008-18.
60. Hickey, M.J., Bullard, D.C., Issekutz, A. and James, W.G. Leukocyte-endothelial cell interactions are enhanced in dermal post-capillary venules of MRL/fas(lpr) (lupus-prone) mice: Roles of P- and E-selectin. J Immunol 2002, 168: 4728-36.
61. Katakai, T., Mori, K.J., Masuda, T. and Shimizu, A. Selective accumulation of type 1 effector cells expressing P-selectin ligand and/or alpha(4)beta(7)-integrin at the lesions of autoimmune gastritis. Int Immunol 2002, 14: 167-75.
62. Salmi, M. and Jalkanen, S. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol 2001, 166: 4650-7.
63. Lee, S.J. and Benveniste, E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J Neuroimmunol 1999, 98: 77-88.
64. Piccio, L., Rossi, B., Scarpini, E. et al. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: Critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors. J Immunol 2002, 168: 1940-9.
65. Carrithers, M.D., Visintin, I., Kang, S.J. and Janeway, C.A., Jr. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 2000, 123(Pt 6): 1092-101.
66. Kerfoot, S.M. and Kubes, P. Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 2002, 169: 1000-6.
67. Battistini, L., Piccio, L., Rossi, B. et al. CD8+ lymphocytes from acute multiple sclerosis patients display selective increase of adhesiveness in brain venules: A critical role for P-selectin-glycoprotein ligand-1. Blood 2003, 101: 4775-82.
68. Hicks, A.E., Leppanen, A., Cummings, R.D., McEver, R.P., Hellewell, P.G. and Norman, K.E. Glycosulfopeptides modeled on P-selectin glycoprotein ligand 1 inhibit P-selectin-dependent leukocyte rolling in vivo. FASEB J 2002, 16: 1461-2.
69. Haddad, W., Cooper, C.J., Zhang, Z. et al. P-selectin and P-selectin glycoprotein ligand 1 are major determinants for ThI cell recruitment to nonlymphoid effector sites in the intestinal lamina propria. J Exp Med 2003, 198: 369-77.
70. McCarty, O.J., Tien, N., Bochner, B.S. and Konstantopoulos, K. Exogenous eosinophil activation converts PSGL-1-dependent binding to CD18-dependent stable adhesion to platelets in shear flow. Am J Physiol Cell Physiol 2003, 284: C1223-34.
71. Opal, S.M., Sypek, J.P., Keith, J.C., Jr., Schaub, R.G., Palardy, J.E. and Parejo, N.A. Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection. Shock 2001, 15: 285-90.
72. Borges, E., Pendl, G., Eytner, R., Steegmaier, M., Zollner, O. and Vestweber D. The binding of T cell-expressed P-selectin glycoprotein ligand-1 to E- and P-selectin is differentially regulated. J Biol Chem 1997, 272: 28786-92.
73. Eppihimer, M.J. and Schaub, R.G. Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules. Microcirculation 2001, 8: 15-24.
74. Kyriakides, C., Austen, W., Jr., Wang, Y., Favuzza, J., Moore, F.D., Jr. and Hechtman, H.B. Endothelial selectin blockade attenuates lung permeability of experimental acid aspiration. Surgery 2000, 128: 327-31.
75. Herron, M.J., Nelson, C.M., Larson, J., Snapp, K.R., Kansas, G.S. and Goodman J.L. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science 2000, 288: 1653-6.
76. Vajkoczy, P., Blum, S., Lamparter, M. et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003, 197: 1755-65.